HER2阳性早期乳腺癌患者接受辅助曲妥珠单抗治疗的长期结局数据:临床试验外的获益

{"title":"HER2阳性早期乳腺癌患者接受辅助曲妥珠单抗治疗的长期结局数据:临床试验外的获益","authors":"Quintyne Ki, B Woulfe, Coffey Jc, Gupta Rk","doi":"10.33582/2640-8198/1002","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":92983,"journal":{"name":"Annals of breast cancer and therapy","volume":"9 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2018-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Long-term outcome data for patients with HER2- positive early-stage breast cancer treated with adjuvant trastuzumab: Benefit outside clinical trial setting\",\"authors\":\"Quintyne Ki, B Woulfe, Coffey Jc, Gupta Rk\",\"doi\":\"10.33582/2640-8198/1002\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":92983,\"journal\":{\"name\":\"Annals of breast cancer and therapy\",\"volume\":\"9 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-07-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Annals of breast cancer and therapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.33582/2640-8198/1002\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of breast cancer and therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33582/2640-8198/1002","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}